South Africa: Stocks of Snake Antivenom Are Dangerously Low, Experts Warn

South Africa's only snake antivenom producer can't make enough of its polyvalent antivenom, which treats bites of at least ten venomous snakes.

Johan Marais, CEO of the African Snakebite Institute, says it's a"major disaster" that doctors and vets can't get hold of the polyvalent antivenom. The polyvalent antivenom is the gold standard for the treatment of venomous snake bites and is produced in Johannesburg by the South African Vaccine Producers , a subsidiary of the National Health Laboratory Service . This antivenom treats snakebites from the Black Mamba, Green Mamba, Jameson's Mamba, Cape Cobra, Forest Cobra, Snouted Cobra, Mozambique Spitting Cobra, Rinkhals, Puff Adder and Gaboon Viper.

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Stocks of snake antivenom are dangerously low, experts warnA massive production backlog at the South African Vaccine Producer has led to shortages at health facilities, especially among veterinarians. Antivenom is racist
Fonte: ewnupdates - 🏆 30. / 53 Consulte Mais informação »

Maverick News: Asian stocks mixed after China GDP; yen falls: markets wrapStocks in Asia were mixed on Tuesday, with most benchmark indexes in a tight range following the release of China’s latest growth data.
Fonte: dailymaverick - 🏆 3. / 84 Consulte Mais informação »

International Finance: Stocks waver as traders weigh earnings, rate path: markets wrapUS stocks fluctuated in early trading as companies including Goldman Sachs Group and Whirlpool reported disappointing earnings and traders assessed the path forward for central bank tightening.
Fonte: dailymaverick - 🏆 3. / 84 Consulte Mais informação »